Tern Plc Wyld Networks warrant exercise

TERN

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has announced that it has committed to exercise the 320,454 TO1 Warrants in Wyld Networks AB which represents all of the TO1 Warrants that were issued to Tern pursuant to its investment as part of Wyld Networks’ Offering in conjunction with Wyld Networks’ IPO and admission to trading on the NASDAQ First North Growth Market in Stockholm on 2 July 2021.

Tern will pay SEK 3,605,108 (approximately £290,000) to exercise its TO1 Warrants to subscribe for 320,454 shares in Wyld Networks at SEK 11.25 per share, and this will be funded from Tern’s existing cash resources.

Prior to the completion of the TO1 Warrant exercises Tern held 58.7% of Wyld Networks’ issued share capital.  The subscription period for the in aggregate, 2,275,000 TO1 Warrants commenced on 22 March 2022 and will end on 4 April 2022.  If all of the TO1 Warrants are exercised Tern’s holding in Wyld Networks will reduce to 49.1% and a further announcement regarding Tern’s resultant holding in Wyld Networks will be made when the exercise period for the TO1 Warrants is completed.

Wyld Networks is a virtual satellite network operator that develops and delivers innovative wireless technology solutions that enable affordable connectivity for IoT devices and sensors anywhere in the world – especially for the 85% of the world’s surface where there are no cellular networks.  For the year ended 31 December 2020, Wyld Networks’ audited loss for the year was SEK 9,536,000 (2019: loss of SEK 6,602,000) on net sales of SEK 2,475,000 (2019: SEK 1,559,000) and its audited total assets as at 31 March 2020 were SEK 5,752,000 (31 December 2019: SEK 5,636,000).

Capitalised terms not otherwise defined herein have the same meaning as in the Tern plc announcement “Proposed IPO of Wyld Networks” made on 9 June 2021.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Search